ICIsGustave Roussy Institutemismatch repair-deficient endometrial cancerendometrial cancerMMRd endometrial cancerEC
…Background Immune checkpoint inhibitors (ICIs) have transformed the treatment for Mismatch repair-deficient (…
45articles mentioning drugs
52drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: ICIs ×
ICIs
This drug is selected. Its supporting articles are shown below.
Articles mentioning ICIs
45 articles · page 4 of 484.5%
checkpoint inhibitorsICIsmelanomaFox Chase Cancer Center
…tes such as the liver, which is significantly more resistant to checkpoint inhibitors (ICIs).Methods Using syngeneic melanoma cells, we optimized int…
ICIsGlioblastomaGBM
…atients survive five years. While immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy, their efficacy in GBM is h…
immune checkpoint inhibitorsICIscancer types
…th large-scale retrospective studies showing that administering immune checkpoint inhibitors (ICIs) earlier in the day is associated with significantly impr…
Immune checkpoint inhibitorsICIsir-adrenalitisir-thyroiditis thyrotoxic phaseir-thyroiditis hypothyroidismir-hypophysitisir-Graves’ diseaseir-type 1 diabetes mellitusRAND/University of California Los Angelescancer
…Immune checkpoint inhibitors (ICIs) are an important class of cancer treatment. Endocrine im…
Immune checkpoint inhibitorsICIsadvanced cancerESCtertiary referral centrecombination ICI therapyICI therapy
…Aims Immune checkpoint inhibitors (ICIs) have transformed the management of advanced cancer, but …
ICIsimmune checkpoint inhibitorsCirAEsirAEsautoimmune skin diseasesadvanced cancers
…Background Although immune checkpoint inhibitors (ICIs) are efficacious, they often cause immune-related adverse event…
pembrolizumabDDTICIsLung cancerMelanoma6melanomagastric cancerbreast cancercolorectal cancernon-small cell lung cancer+4 more
…mall cell lung cancer (NSCLC).12 13 However, the superiority of pembrolizumab over chemotherapy in this setting had already been demonstrated…
immune checkpoint inhibitorsICIsnon-small cell lung cancerLung adenocarcinoma (LUAD)LUAD
…the most common subtype of non-small cell lung cancer. Although immune checkpoint inhibitors (ICIs) have brought new treatment options for advanced patients…